Evidence map›Paper›PMID 37837323›Full record

ArticleJournal of neuropathology and experimental neurology2023

Validating MCM2 as a clinically relevant surrogate immunohistochemical marker for an aggressive meningioma molecular subtype.

Allison Shelbourn, Nicholas Nuechterlein, Carolina Angelica Parada, Jessica Eaton, Mallory Tucker, Manuel Ferreira, Patrick J Cimino

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of neuropathology and experimental neurology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Allison ShelbournNeuropathology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Nicholas NuechterleinNeuropathology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.
Carolina Angelica ParadaDepartment of Neurological Surgery, University of Washington, Seattle, Washington, USA.
Jessica EatonDepartment of Neurological Surgery, University of Washington, Seattle, Washington, USA.
Mallory TuckerDepartment of Neurological Surgery, University of Washington, Seattle, Washington, USA.
Manuel FerreiraDepartment of Neurological Surgery, University of Washington, Seattle, Washington, USA.
Patrick J CiminoNeuropathology Unit, Surgical Neurology Branch, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Maryland, USA.ORCID 0000-0003-0441-4502

Funding

NIH HHSNINDS NIH HHS
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Meningeal NeoplasmsMeningiomaHumansMinichromosome Maintenance Complex Component 2MCM2 protein, humanMinichromosome Maintenance Complex Component 2

Identifiers

PMID37837323
PMCPMC11032699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.